CINA CHEST vs Cleerly ISCHEMIA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Avicenna.AI
VS
by Cleerly

AI Verdict

These tools are adjacent rather than direct competitors, as they address different clinical needs within cardiovascular imaging. CINA CHEST is designed for rapid triage and notification of acute, life-threatening conditions like Pulmonary Embolism and Aortic Dissection. In contrast, Cleerly ISCHEMIA focuses on detailed analysis of CCTA scans to assess chronic coronary artery disease, ischemia likelihood, and plaque characteristics for personalized diagnosis and treatment planning.

Choose CINA CHEST if…

Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for acute, life-threatening chest conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD) in an emergency setting. This tool is ideal for quickly flagging suspected positive findings on CT angiography scans to prioritize urgent cases and streamline emergency radiology workflows.

View CINA CHEST →

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a comprehensive, non-invasive AI analysis of CCTA scans to determine the likelihood of coronary artery ischemia at a vessel level. This tool is best suited for detailed personalized diagnosis, treatment planning, and understanding coronary plaque characteristics and stenosis severity in patients with suspected or known heart disease.

View Cleerly ISCHEMIA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CINA CHEST Cleerly ISCHEMIA
Pricing Subscription-based Contact for details
Deployment Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker) Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance)
FDA Status K210237 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CINA CHEST

CINA CHEST, particularly with the recent launch of Avicenna.AI's AVI platform, emphasizes a 'fast, automatic, and invisible' integration directly into existing PACS and RIS without requiring new viewers, worklists, or workflow changes. This focus on minimal disruption and no extra training for clinicians suggests a superior user experience for rapid triage in emergency settings.

Clinical Value

CINA CHEST

CINA CHEST provides rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD), with reported mean time-to-notification as low as 36.5 seconds for AD. Its role in emergency triage directly impacts immediate patient outcomes by flagging critical findings for urgent intervention.

Pricing & Value

Cleerly ISCHEMIA

While both tools require contacting for specific pricing, Cleerly ISCHEMIA offers more transparency by mentioning its billability under Category I CPTu00ae Codes 75580 and 75577, with a global reimbursement rate of $1,026 for plaque analysis (CPT 75577) as of 2026. This provides clearer guidance for providers on potential reimbursement and economic value.

Enterprise Readiness

CINA CHEST

CINA CHEST offers more flexible deployment options including cloud-based, on-premise, and virtualized environments, catering to diverse IT infrastructures. Furthermore, Avicenna.AI's AVI platform is designed for seamless integration with existing PACS/RIS, supporting global interoperability standards like DICOM, HL7, and FHIR, and is built for GDPR- and HIPAA-compliant workflows across various healthcare settings.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA demonstrates a deeper innovation by non-invasively estimating fractional flow reserve (FFR) and providing detailed coronary plaque characterization (volume, type, location), moving beyond anatomical assessment to functional ischemia. This comprehensive approach aims to redefine heart disease diagnosis and personalize treatment planning, with studies showing a reduction in further invasive testing and an increase in preventive medications.

Support & Docs

CINA CHEST

While both companies offer customer support, Avicenna.AI specifically mentions 'Avicenna Scribe for Customer support' which includes features like summaries, QA tagging, and QA escalation triggers for every call. This suggests a more structured and potentially proactive approach to managing and improving support interactions.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CINA CHEST Cleerly ISCHEMIA
Tool Name CINA CHEST Cleerly ISCHEMIA
Company Avicenna.AI Cleerly
Primary Clinical Focus Rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease.
Core Functionality 1 Radiological computer-aided triage and notification. AI-enabled CCTA analysis for non-invasive ischemia detection.
Core Functionality 2 Detection of Pulmonary Embolism (PE) and Aortic Dissection (AD). Vessel-level ischemia likelihood determination and coronary plaque characterization.

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and Cleerly ISCHEMIA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CINA CHEST is designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans, assisting in emergency radiology triage. Cleerly ISCHEMIA analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease.
CINA CHEST is designed to analyze Chest CT angiography and Chest or Thoraco-abdominal CT angiography scans. Cleerly ISCHEMIA specifically utilizes CCTA (Coronary CT Angiography) scans for its analysis.
CINA CHEST flags and communicates suspected positive findings of PE and AD, providing notifications with compressed preview images for informational purposes and workflow triage. Cleerly ISCHEMIA provides vessel-level ischemia likelihood determination, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), stenosis severity assessment, and comprehensive interactive web-based reports.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.